Arcutis Biotherapeutics (ARQT) Event Aug. 04, 2022, 21:25 UTC 21 1 comments (30% Negative) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Reports Q3 2022 Financial Results Comment Full text
Keros Therapeutics Inc (KROS) Event Aug. 04, 2022, 21:13 UTC 18 1 comments (10% Negative) Keros Therapeutics, Inc. (KROS) Announces Delay in trials Trials for KER-050 Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Poseida Therapeutics (PSTX) Event Aug. 04, 2022, 20:57 UTC 24 1 comments (99% Neutral) Poseida Therapeutics, Inc. (PSTX) Files Form 8-K Comment Full text
BridgeBio Pharma (BBIO) Event Aug. 04, 2022, 20:43 UTC 19 1 comments (10% Negative) BridgeBio Pharma, Inc. (BBIO) Reports Q3 2022 Financial Results Comment Full text
Sana Biotechnology Inc (SANA) Event Aug. 04, 2022, 20:42 UTC 20 1 comments (30% Negative) SANA BIOTECHNOLOGY, INC. (SANA) Reports Q3 2022 Financial Results Comment Full text
Gritstone Oncology Inc (GRTS) Event Aug. 04, 2022, 20:41 UTC 24 1 comments (30% Negative) Gritstone bio, Inc. (GRTS) Reports Q3 2022 Financial Results Comment Full text
Cellectis (CLLS) Event Aug. 04, 2022, 20:39 UTC 14 1 comments (10% Negative) Cellectis (CLLS) Reports Q3 2022 Financial Results (Form 6-K) Comment Full text
Alector Inc (ALEC) Event Aug. 04, 2022, 20:33 UTC 24 1 comments (75% Positive) Alector, Inc. (ALEC) Announces Enrollment Update for submitted Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Generation Bio (GBIO) Event Aug. 04, 2022, 20:26 UTC 25 1 comments (98% Positive) Generation Bio Co. (GBIO) Reports Q3 2022 Financial Results Comment Full text
Coherus BioSciences Inc (CHRS) Event Aug. 04, 2022, 20:25 UTC 24 1 comments (30% Negative) COHERUS BIOSCIENCES, INC. (CHRS) Reports Q3 2022 Financial Results Comment Full text